GE's non-invasive SMS-EIT prototype system provides higher signal-to-noise ratio and greater sensitivity to continuously image pulmonary perfusion and ventilation.

Low-cost manufacturing platform for disposable, hospital-grade multi-parameter clinical monitoring devices.

Hydration status monitoring based on wearable sweat-based sensing

Leveraging time-sensitive quantum key distribution technology to provide industrial and utility networks with simpler, more deterministic, and secure communication.

Materials development and optimization to enable high color quality, more energy efficient displays and lighting products

Imaging is an essential non-invasive tool for building disease understanding and characterization. Contrast agents or targeted imaging (molecular imaging) allow specific features to be delineated, such as vascularization, abnormal metabolism, or disease-specific biomarkers. GE Research has an active program developing molecular imaging agents that benefits from our strong capabilities in diagnostic imaging hardware and histopathogical technology for characterization of biomarkers in diseased tissue.

Developing cutting edge technologies in machine architectures, energy sources, sensing and controls for step-change in build size and speed, while assuring part quality.

Real-time, sub-micron, 3D visualizations of microstructure to create and validate damage accumulation models.

Cell DIVE™ is a powerful and innovative commercial technology platform that enables a researcher to analyze single 5 um tissue section with up to 60 biomarker stains.

GE Research developed a novel method for automated tissue multiplexing.